Filgrastim to treat neutropenia and support myelosuppressive medication dosing in HIV infection. AIDS 1996;10:1627±1633.Hermans P, Rosenbaum W, Jou A, et al. Filgrastim to treat neutropenia and support myelosuppressive medication dosing in HIV infection. G-CSF 92105 study group. AIDS 1996; 10(...
5–10mg PO or IV every 6–8h not to exceed 40mg/day. 25mg Suppository every 12h CNS: Depression Anticholinergic symptoms (constipation, xerostomia, blurred vision, urinary retention) Leukopenia, agranulocytosis, neutropenia Extrapyramidal symptoms ...
but there are no guidelines or at least a “general rule of thumb” as to when it should be prescribed. Since myelosuppressive chemotherapy can lead to profound and sometimes prolonged neutropenia, which may result in hospitalization so as to treat a bout of fever or a potentially...
Since myelo- suppressive chemotherapy can lead to profound and sometimes prolonged neutropenia, which may result in hospitalization so as to treat a bout of fever or a poten- tially life-threatening infection, the use of GCSF and similar agents have a main role in the primary and sec- ondary...
Patients who received one prior line of therapy for LBCL (2L) Grade 3 or higher cytopenias present at Day 29 (or Day 35) following BREYANZI, occurred in 44% (39/89) of patients, and included thrombocytopenia (37%), neutropenia (30%), and anemia (11%). Patients who received two or...
[40] investigated anticoagulant and chemotherapy treat- ment, respectively. Therefore, the medication involved in both studies may not be indicative of the medications that are generally used in the geriatric population. 4 Discussion This scoping review identified nine studies evaluating medi- cation...